Yes, times are tough for everyone.
According to UBS, which looked at a handful of generic drug companies representative of the industry, gross margins fell to 47% in the second year compared to 52.2% a year ago.
That’s right, “fell” to 47%.
Nice work if you can get it.
Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.
